Related Experiment Video
Updated: Feb 7, 2026

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
Published on: May 11, 2020
Smoking-Related Diffuse Cystic Lung Disease
Nishant Gupta1, Thomas V Colby2, Cristopher A Meyer3
1Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, Cincinnati, OH; Medical Service, Veterans Affairs Medical Center, Cincinnati, OH.
Cigarette smoke exposure can cause lung diseases that mimic lymphangioleiomyomatosis (LAM) on CT scans. Histopathology is crucial for diagnosing smoking-related small airway injury, differentiating it from LAM in diffuse cystic lung diseases (DCLDs).
Area of Science:
- Pulmonology
- Radiology
- Pathology
Background:
- Cigarette smoke exposure is a known cause of various parenchymal lung diseases.
- Diffuse cystic lung diseases (DCLDs) encompass a group of conditions affecting lung parenchyma.
- Lymphangioleiomyomatosis (LAM) is a classic DCLD with distinct high-resolution CT (HRCT) imaging features.
Observation:
- Four patients with DCLD on HRCT were initially suspected of having LAM.
- Histopathological analysis revealed smoking-related small airway injury in these patients.
- This suggests a potential imaging overlap between LAM and smoking-induced lung disease.
Findings:
- Smoking-related small airway injury can present radiographically as DCLD on HRCT.
- The imaging findings of this condition can mimic those of LAM.
- Histopathology is essential for accurate diagnosis.
Implications:
- Clinicians should consider detailed smoking history in patients with DCLD.
- HRCT findings alone are insufficient for diagnosing LAM.
- Distinguishing smoking-related DCLD from LAM requires integrating clinical, imaging, and pathological data.
Related Concept Videos
Diffusion
Diffusion
Lung Capacity
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...

